Low-grade, latent prostate cancer volume: Predictor of clinical cancer incidence?

Alice S. Whittemore, Joseph B. Keller, Rebecca Betensky

Research output: Contribution to journalArticle

Abstract

We hypothesize that each cell in lowgrade (Gleason grade 1-3) prostate cancer tissue is at risk of transformation into a cell which produces a highgrade (Gleason grade 4-5) clinical cancer after a short period of growth. As a consequence, the volume of low-grade, latent cancer tissue in the prostate glands of men at any age determines their incidence rate for high-grade, clinical cancer a few years later. Autopsy and incidence data for both white men and black men support this conclusion, with a tumor growth period of about 7 years. The transformation rate is similar for black men and for white men, about 0.024 high-grade cancers per year per cm3 of lowgrade latent cancer volume. Our hypothesis explains the infrequent occurrence of clinical cancer despite the high prevalence of latent cancer, the steep rise of clinical cancer incidence with age despite the slow rise of latent cancer prevalence with age, and the disparities in clinical cancer incidence among some populations despite their similar latent cancer prevalence. This hypothesis suggests that low-grade cancer volume is a critical determinant of clinical cancer risk. [J Natl Cancer Inst 83:1231-1235, 1991]

Original languageEnglish (US)
Pages (from-to)1231-1235
Number of pages5
JournalJournal of the National Cancer Institute
Volume83
Issue number17
DOIs
StatePublished - Sep 4 1991

Fingerprint

Prostatic Neoplasms
Incidence
Neoplasms
Growth
Prostate
Autopsy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Low-grade, latent prostate cancer volume : Predictor of clinical cancer incidence? / Whittemore, Alice S.; Keller, Joseph B.; Betensky, Rebecca.

In: Journal of the National Cancer Institute, Vol. 83, No. 17, 04.09.1991, p. 1231-1235.

Research output: Contribution to journalArticle

@article{28ca29ecfebb464f9e1971a664e48301,
title = "Low-grade, latent prostate cancer volume: Predictor of clinical cancer incidence?",
abstract = "We hypothesize that each cell in lowgrade (Gleason grade 1-3) prostate cancer tissue is at risk of transformation into a cell which produces a highgrade (Gleason grade 4-5) clinical cancer after a short period of growth. As a consequence, the volume of low-grade, latent cancer tissue in the prostate glands of men at any age determines their incidence rate for high-grade, clinical cancer a few years later. Autopsy and incidence data for both white men and black men support this conclusion, with a tumor growth period of about 7 years. The transformation rate is similar for black men and for white men, about 0.024 high-grade cancers per year per cm3 of lowgrade latent cancer volume. Our hypothesis explains the infrequent occurrence of clinical cancer despite the high prevalence of latent cancer, the steep rise of clinical cancer incidence with age despite the slow rise of latent cancer prevalence with age, and the disparities in clinical cancer incidence among some populations despite their similar latent cancer prevalence. This hypothesis suggests that low-grade cancer volume is a critical determinant of clinical cancer risk. [J Natl Cancer Inst 83:1231-1235, 1991]",
author = "Whittemore, {Alice S.} and Keller, {Joseph B.} and Rebecca Betensky",
year = "1991",
month = "9",
day = "4",
doi = "10.1093/jnci/83.17.1231",
language = "English (US)",
volume = "83",
pages = "1231--1235",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - Low-grade, latent prostate cancer volume

T2 - Predictor of clinical cancer incidence?

AU - Whittemore, Alice S.

AU - Keller, Joseph B.

AU - Betensky, Rebecca

PY - 1991/9/4

Y1 - 1991/9/4

N2 - We hypothesize that each cell in lowgrade (Gleason grade 1-3) prostate cancer tissue is at risk of transformation into a cell which produces a highgrade (Gleason grade 4-5) clinical cancer after a short period of growth. As a consequence, the volume of low-grade, latent cancer tissue in the prostate glands of men at any age determines their incidence rate for high-grade, clinical cancer a few years later. Autopsy and incidence data for both white men and black men support this conclusion, with a tumor growth period of about 7 years. The transformation rate is similar for black men and for white men, about 0.024 high-grade cancers per year per cm3 of lowgrade latent cancer volume. Our hypothesis explains the infrequent occurrence of clinical cancer despite the high prevalence of latent cancer, the steep rise of clinical cancer incidence with age despite the slow rise of latent cancer prevalence with age, and the disparities in clinical cancer incidence among some populations despite their similar latent cancer prevalence. This hypothesis suggests that low-grade cancer volume is a critical determinant of clinical cancer risk. [J Natl Cancer Inst 83:1231-1235, 1991]

AB - We hypothesize that each cell in lowgrade (Gleason grade 1-3) prostate cancer tissue is at risk of transformation into a cell which produces a highgrade (Gleason grade 4-5) clinical cancer after a short period of growth. As a consequence, the volume of low-grade, latent cancer tissue in the prostate glands of men at any age determines their incidence rate for high-grade, clinical cancer a few years later. Autopsy and incidence data for both white men and black men support this conclusion, with a tumor growth period of about 7 years. The transformation rate is similar for black men and for white men, about 0.024 high-grade cancers per year per cm3 of lowgrade latent cancer volume. Our hypothesis explains the infrequent occurrence of clinical cancer despite the high prevalence of latent cancer, the steep rise of clinical cancer incidence with age despite the slow rise of latent cancer prevalence with age, and the disparities in clinical cancer incidence among some populations despite their similar latent cancer prevalence. This hypothesis suggests that low-grade cancer volume is a critical determinant of clinical cancer risk. [J Natl Cancer Inst 83:1231-1235, 1991]

UR - http://www.scopus.com/inward/record.url?scp=0026075624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026075624&partnerID=8YFLogxK

U2 - 10.1093/jnci/83.17.1231

DO - 10.1093/jnci/83.17.1231

M3 - Article

VL - 83

SP - 1231

EP - 1235

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 17

ER -